TMUB1
gene geneOn this page
Also known as SB144HOPS
Summary
TMUB1 (transmembrane and ubiquitin like domain containing 1, HGNC:21709) is a protein-coding gene on chromosome 7q36.1, encoding Transmembrane and ubiquitin-like domain-containing protein 1 (Q9BVT8). Involved in sterol-regulated ubiquitination and degradation of HMG-CoA reductase HMGCR.
Involved in ERAD pathway. Predicted to be located in several cellular components, including centrosome; postsynaptic membrane; and recycling endosome. Predicted to be active in postsynaptic recycling endosome membrane.
Source: NCBI Gene 83590 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 37 total
- MANE Select transcript:
NM_001136044
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21709 |
| Approved symbol | TMUB1 |
| Name | transmembrane and ubiquitin like domain containing 1 |
| Location | 7q36.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SB144, HOPS |
| Ensembl gene | ENSG00000164897 |
| Ensembl biotype | protein_coding |
| OMIM | 614792 |
| Entrez | 83590 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 15 protein_coding
ENST00000297533, ENST00000392818, ENST00000462940, ENST00000476627, ENST00000482202, ENST00000488752, ENST00000492838, ENST00000653405, ENST00000873650, ENST00000873651, ENST00000873652, ENST00000873653, ENST00000873654, ENST00000924882, ENST00000924883
RefSeq mRNA: 2 — MANE Select: NM_001136044
NM_001136044, NM_031434
CCDS: CCDS5920
Canonical transcript exons
ENST00000297533 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001088367 | 151082175 | 151082593 |
| ENSE00001088369 | 151083434 | 151083493 |
| ENSE00001825881 | 151081085 | 151081900 |
Expression profiles
Bgee: expression breadth ubiquitous, 139 present calls, max score 96.33.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.2561 / max 226.8990, expressed in 1809 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 86864 | 20.2572 | 1804 |
| 86863 | 1.4343 | 367 |
| 86865 | 0.5647 | 320 |
Top tissues by expression
141 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 96.33 | gold quality |
| right lobe of liver | UBERON:0001114 | 95.87 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 95.79 | gold quality |
| body of pancreas | UBERON:0001150 | 95.66 | gold quality |
| thymus | UBERON:0002370 | 95.27 | silver quality |
| body of stomach | UBERON:0001161 | 95.04 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 94.65 | gold quality |
| gastrocnemius | UBERON:0001388 | 94.57 | gold quality |
| adenohypophysis | UBERON:0002196 | 94.48 | gold quality |
| fundus of stomach | UBERON:0001160 | 94.44 | gold quality |
| pituitary gland | UBERON:0000007 | 94.29 | gold quality |
| apex of heart | UBERON:0002098 | 94.28 | gold quality |
| granulocyte | CL:0000094 | 93.81 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 93.50 | gold quality |
| duodenum | UBERON:0002114 | 93.44 | gold quality |
| muscle of leg | UBERON:0001383 | 93.34 | gold quality |
| transverse colon | UBERON:0001157 | 93.30 | gold quality |
| metanephros cortex | UBERON:0010533 | 93.28 | gold quality |
| small intestine | UBERON:0002108 | 93.13 | gold quality |
| liver | UBERON:0002107 | 93.09 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 93.01 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 92.82 | gold quality |
| lower esophagus | UBERON:0013473 | 92.80 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 92.80 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 92.60 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 92.58 | gold quality |
| mucosa of stomach | UBERON:0001199 | 92.56 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 92.48 | gold quality |
| blood | UBERON:0000178 | 92.46 | gold quality |
| popliteal artery | UBERON:0002250 | 92.41 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.24 |
| E-MTAB-6379 | no | 52.29 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
11 targeting TMUB1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
| HSA-MIR-6793-3P | 97.66 | 65.78 | 1084 |
| HSA-MIR-1913 | 97.07 | 66.20 | 1417 |
| HSA-MIR-5587-3P | 82.90 | 60.79 | 138 |
Literature-anchored findings (GeneRIF, showing 7)
- a novel ubiquitin-like molecule DULP from human dendritic cells was identified. (PMID:19254477)
- TMUB1 promoted the expression of STAT1, and suppressed the expression of CCND1 in HCC cells. TMUB1 negatively regulates hepatocellular carcinoma proliferation via regulating STAT1. (PMID:31827061)
- The Ins and Outs of HOPS/TMUB1 in biology and pathology. (PMID:32860479)
- TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for Colorectal Cancer. (PMID:35928927)
- Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation. (PMID:36376293)
- Inhibition of TMUB1 blocks apoptosis and NF-kappaB pathway-mediated inflammation in recurrent spontaneous abortion. (PMID:37249279)
- TMUB1 expression is associated with the prognosis of colon cancer and immune cell infiltration. (PMID:38025742)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmub1 | ENSDARG00000038787 |
| mus_musculus | Tmub1 | ENSMUSG00000028958 |
| rattus_norvegicus | Tmub1 | ENSRNOG00000013383 |
| caenorhabditis_elegans | WBGENE00015126 |
Paralogs (1): TMUB2 (ENSG00000168591)
Protein
Protein identifiers
Transmembrane and ubiquitin-like domain-containing protein 1 — Q9BVT8 (reviewed: Q9BVT8)
Alternative names: Dendritic cell-derived ubiquitin-like protein, Hepatocyte odd protein shuttling protein, Ubiquitin-like protein SB144
All UniProt accessions (5): A0A090N8Q3, A0A590UJA9, C9JCW7, C9JE12, Q9BVT8
UniProt curated annotations — full annotation on UniProt →
Function. Involved in sterol-regulated ubiquitination and degradation of HMG-CoA reductase HMGCR. Involved in positive regulation of AMPA-selective glutamate receptor GRIA2 recycling to the cell surface. Acts as a negative regulator of hepatocyte growth during regeneration. May contribute to the regulation of translation during cell-cycle progression. May contribute to the regulation of cell proliferation. May be involved in centrosome assembly. Modulates stabilization and nucleolar localization of tumor suppressor CDKN2A and enhances association between CDKN2A and NPM1.
Subunit / interactions. Interacts with EEF1A1, GRIA2, GRIP1, CAMLG, TUBG1. Interacts with NPM1 and CDKN2A; TMUB1 can enhance interaction between NPM1 and CDKN2A and is proposed to bridge the proteins; proposed to be mediated by iHOPS. Interacts with ERLIN2 and AMFR; TMUB1 promotes the interaction of ERLIN2 with AMFR.
Subcellular location. Membrane. Postsynaptic cell membrane. Recycling endosome. Cytoplasm. Nucleus. Nucleolus Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Nucleolus.
Tissue specificity. Ubiquitously expressed with highest levels in mammary and thyroid glands, bone marrow and spleen; limited expression in cardiac, pancreatic and ovarian tissues.
Post-translational modifications. Processed by regulated intramembrane proteolysis (RIP)in the N-terminus to release iHOPS from membranes.
RefSeq proteins (2): NP_001129516, NP_113622 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000626 | Ubiquitin-like_dom | Domain |
| IPR029071 | Ubiquitin-like_domsf | Homologous_superfamily |
| IPR040352 | TMUB1/2 | Family |
Pfam: PF00240
UniProt features (14 total): modified residue 5, transmembrane region 3, chain 2, region of interest 2, domain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BVT8-F1 | 67.20 | 0.04 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (5): 73, 92, 98, 127, 71
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 78 (showing top):
GOBP_RESPONSE_TO_NITROGEN_COMPOUND, GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOCC_CENTROSOME, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, GOBP_ERAD_PATHWAY, GOBP_PROTEIN_CATABOLIC_PROCESS, GOCC_POSTSYNAPSE, GOCC_SYNAPSE, GOCC_POSTSYNAPTIC_MEMBRANE, GOBP_PROTEOLYSIS, GOCC_PLASMA_MEMBRANE_REGION, GOCC_NUCLEOLUS, GOCC_RECYCLING_ENDOSOME
GO Biological Process (1): ERAD pathway (GO:0036503)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (11): nucleolus (GO:0005730), centrosome (GO:0005813), postsynaptic membrane (GO:0045211), recycling endosome (GO:0055037), nucleus (GO:0005634), cytoplasm (GO:0005737), endosome (GO:0005768), cytoskeleton (GO:0005856), plasma membrane (GO:0005886), membrane (GO:0016020), synapse (GO:0045202)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membraneless organelle | 2 |
| cellular anatomical structure | 2 |
| proteasomal protein catabolic process | 1 |
| response to endoplasmic reticulum stress | 1 |
| response to chemical | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| synaptic membrane | 1 |
| postsynapse | 1 |
| endosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| endomembrane system | 1 |
| cytoplasmic vesicle | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cell junction | 1 |
Protein interactions and networks
STRING
814 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMUB1 | TMEM259 | Q4ZIN3 | 851 |
| TMUB1 | ERLIN2 | O94905 | 747 |
| TMUB1 | RNF185 | Q96GF1 | 701 |
| TMUB1 | AMFR | P26442 | 660 |
| TMUB1 | ERLIN1 | O75477 | 625 |
| TMUB1 | A0A2R8Y422 | A0A2R8Y422 | 576 |
| TMUB1 | FAM8A1 | Q9UBU6 | 574 |
| TMUB1 | RNF170 | Q96K19 | 557 |
| TMUB1 | TMEM126A | Q9H061 | 546 |
| TMUB1 | C6orf120 | Q7Z4R8 | 495 |
| TMUB1 | UBE2G2 | P56554 | 461 |
| TMUB1 | TMEM53 | Q6P2H8 | 461 |
| TMUB1 | TMUB2 | Q71RG4 | 456 |
| TMUB1 | UBE2J1 | Q9Y385 | 456 |
| TMUB1 | PLEKHM1 | Q9Y4G2 | 446 |
IntAct
74 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ERLIN1 | ERLIN2 | psi-mi:“MI:0914”(association) | 0.740 |
| ERLIN2 | TMUB1 | psi-mi:“MI:0915”(physical association) | 0.660 |
| ERLIN2 | TMUB1 | psi-mi:“MI:0914”(association) | 0.660 |
| TMUB1 | ERLIN2 | psi-mi:“MI:0915”(physical association) | 0.660 |
| TMUB1 | ERLIN2 | psi-mi:“MI:0914”(association) | 0.660 |
| TMUB1 | AMFR | psi-mi:“MI:0915”(physical association) | 0.560 |
| SGTB | TMUB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLM1 | TMUB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMBIM6 | TMUB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMUB1 | TMEM14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMUB1 | JPH3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ADGRG5 | KLRG2 | psi-mi:“MI:0914”(association) | 0.530 |
| RIC3 | ATP9A | psi-mi:“MI:0914”(association) | 0.530 |
| DUSP3 | ERLIN1 | psi-mi:“MI:0914”(association) | 0.530 |
| ANKH | FAM234B | psi-mi:“MI:0914”(association) | 0.530 |
| TMUB1 | SYVN1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| RNF139 | TMUB1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| KISS1R | ERLIN1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ERLIN2 | psi-mi:“MI:0914”(association) | 0.350 | |
| CHRNA9 | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| KCNK16 | EMC8 | psi-mi:“MI:0914”(association) | 0.350 |
| RIC3 | ATP9A | psi-mi:“MI:0914”(association) | 0.350 |
| TMUB2 | ERLIN1 | psi-mi:“MI:0914”(association) | 0.350 |
| NBAS | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (152): TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS)
ESM2 similar proteins: A7E3N7, B1AVH7, B5DFA1, D2H0G5, D3ZZN9, E9PY61, E9Q6X9, O75425, O95382, Q0QWG9, Q24JP5, Q3T033, Q3ZBI9, Q53AQ4, Q5TG30, Q60806, Q6F5E8, Q6PGG2, Q6V7V2, Q6ZW31, Q76MJ5, Q7Z465, Q80WF4, Q8BGG6, Q8C0R7, Q8C6B2, Q8CJ00, Q8R2K4, Q8WVB6, Q91WA6, Q922P8, Q924T7, Q969H4, Q96EP0, Q96F46, Q99JU7, Q9BST9, Q9BVT8, Q9BXM7, Q9DBZ9
Diamond homologs: P34256, Q2HJA8, Q3KPV4, Q3V209, Q3ZBI9, Q4FZV7, Q4V9Y1, Q53AQ4, Q6P135, Q71RG4, Q9BVT8, Q9JMG3
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 75 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Calnexin/calreticulin cycle | 5 | 70.0× | 2e-06 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 5 | 41.5× | 1e-05 |
| Defective CFTR causes cystic fibrosis | 5 | 21.5× | 2e-04 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | 5 | 19.0× | 2e-04 |
| ABC-family protein mediated transport | 5 | 11.9× | 2e-03 |
| SLC-mediated transmembrane transport | 8 | 9.3× | 1e-04 |
| Transport of small molecules | 11 | 5.4× | 2e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| ERAD pathway | 9 | 24.7× | 4e-08 |
| transmembrane transport | 6 | 15.3× | 4e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
37 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 35 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
681 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:151081901:C:CC | acceptor_gain | 1.0000 |
| 7:151081902:T:C | acceptor_loss | 1.0000 |
| 7:151082171:TTA:T | donor_loss | 1.0000 |
| 7:151082173:A:AC | donor_gain | 1.0000 |
| 7:151082174:C:CC | donor_gain | 1.0000 |
| 7:151083432:ACCGC:A | donor_gain | 1.0000 |
| 7:151083433:CCGCC:C | donor_gain | 1.0000 |
| 7:151081896:GGGTC:G | acceptor_gain | 0.9900 |
| 7:151081898:GTC:G | acceptor_gain | 0.9900 |
| 7:151081899:TC:T | acceptor_gain | 0.9900 |
| 7:151081900:CC:C | acceptor_gain | 0.9900 |
| 7:151082170:CTTA:C | donor_gain | 0.9900 |
| 7:151082173:AC:A | donor_gain | 0.9900 |
| 7:151082174:CC:C | donor_gain | 0.9900 |
| 7:151082174:CCT:C | donor_gain | 0.9900 |
| 7:151082174:CCTT:C | donor_gain | 0.9900 |
| 7:151082174:CCTTT:C | donor_gain | 0.9900 |
| 7:151082498:C:CT | acceptor_gain | 0.9900 |
| 7:151082589:CCGAG:C | acceptor_gain | 0.9900 |
| 7:151082590:CGAG:C | acceptor_gain | 0.9900 |
| 7:151082590:CGAGC:C | acceptor_gain | 0.9900 |
| 7:151082594:C:CC | acceptor_gain | 0.9900 |
| 7:151083426:GGACT:G | donor_loss | 0.9900 |
| 7:151083427:GACT:G | donor_loss | 0.9900 |
| 7:151083428:ACTC:A | donor_loss | 0.9900 |
| 7:151083429:CTC:C | donor_loss | 0.9900 |
| 7:151083430:TCA:T | donor_loss | 0.9900 |
| 7:151083431:CA:C | donor_loss | 0.9900 |
| 7:151083432:A:AC | donor_gain | 0.9900 |
| 7:151083432:A:T | donor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000693573 (7:151080811 G>A), RS1001512726 (7:151080781 G>A,C), RS1002326513 (7:151084183 A>T), RS1002778273 (7:151083886 C>A,T), RS1003410218 (7:151082946 T>G), RS1003777174 (7:151082696 C>T), RS1004651210 (7:151084221 C>T), RS1004810846 (7:151081378 A>G,T), RS1005918073 (7:151084827 C>A,T), RS1006494715 (7:151085034 C>A), RS1006714174 (7:151081140 T>C), RS1007097750 (7:151081454 C>T), RS1008503443 (7:151082238 A>G,T), RS1009507801 (7:151080891 C>G,T), RS1009944318 (7:151085453 G>A,C)
Disease associations
OMIM: gene MIM:614792 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003476_9 | Eyebrow thickness | 7.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 3 |
| aristolochic acid I | increases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| abrine | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| MT19c compound | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Caffeine | affects phosphorylation | 1 |
| Gallic Acid | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2IX | Abcam HeLa TMUB1 KO | Cancer cell line | Female |
| CVCL_B2IY | Abcam HeLa TMUB1 partial KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.